to evaluate postgrafting prophylaxis for graft-versus-host disease ( gvhd ) , the patients were entered into a randomized prospective trial comparing a combination of methotrexate and cyclosporin ( n = 22 ) to methotrexate alone ( n = 24 ) .
C0018133
graft-versus-host disease
C0010592
cyclosporin